30 studies found for:    " August 04, 2010":" September 03, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: GSK1349572;   Drug: Fosamprenavir;   Drug: Ritonavir
22 Terminated
Has Results
Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infection
Conditions: Hepatitis C;   HIV
Intervention:
23 Completed PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial
Condition: HIV-1
Interventions: Drug: Efavirenz or Nevirapine;   Drug: Ritonavir-boosted lopinavir
24 Unknown  HIV Indicator Diseases Survey Across Europe - UK Arm
Conditions: HIV;   AIDS;   Indicator Diseases/Indicator Conditions
Interventions: Other: HIV test (serological or salivary);   Other: Interview
25 Completed Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?
Conditions: Human Immunodeficiency Virus;   Herpes Simplex
Interventions: Drug: Valacyclovir;   Drug: Placebo
26 Withdrawn Project AWARE: Using the Emergency Department (ED) to Prevent Sexually Transmitted Infections (STIs) in Youth
Conditions: Chlamydia;   Gonorrhea;   HIV
Interventions: Behavioral: HIV testing;   Behavioral: STI/HIV-T;   Behavioral: STI/HIV-Plus
27 Completed Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure
Conditions: HIV;   AIDS;   Lopinavir;   Treatment Failure
Interventions: Drug: Ritonavir-boosted lopinavir;   Drug: optimized background regimens (OBRs)
28 Active, not recruiting Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
Conditions: AIDS-Related Diffuse Large Cell Lymphoma;   AIDS-Related Plasmablastic Lymphoma;   AIDS-Related Primary Effusion Lymphoma;   Grade 3b Follicular Lymphoma;   HIV Infection;   Plasmablastic Lymphoma;   Primary Effusion Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Stage I Adult Diffuse Large Cell Lymphoma;   Stage I Grade 3 Follicular Lymphoma;   Stage II Contiguous Adult Diffuse Large Cell Lymphoma;   Stage II Grade 3 Contiguous Follicular Lymphoma;   Stage II Grade 3 Non-Contiguous Follicular Lymphoma;   Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Grade 3 Follicular Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate;   Drug: Vorinostat
29 Completed
Has Results
Typing of Human Papilloma Virus (HPV) From Female Genital Warts
Conditions: Genital Warts;   Human Papilloma Virus
Intervention: Procedure: Medical / Surgical Treatment
30 Withdrawn Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study
Condition: Herpes Zoster
Intervention: Biological: Zostavax

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Study has passed its completion date and status has not been verified in more than two years.